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It has become evident that combinatorial treatments with "old fashioned" chemo- and radiotherapy together with DC vaccines, T cell-based approaches therapy by small molecules or novel immunotherapeutic strategies with antibodies are the most promising approaches, but the combinations and sequence of administration has still to be investigated and appear to be tumor specific.